The establishment and characterization of a reticuloendotheliosis virus (strain T)-transformed lymphoblastoid cell line, designated TV-1, was reported. These cells, isolated from the spleen of a moribund chick infected with reticuloendotheliosis virus, were maintained in suspension culture for over 74 weeks at a stable generation time of 15 h. The cells were found to carry a female karyotype. Both TV-1 cells and cell-free TV-1 culture supernatant produced lesions and mortality patterns in chicks which were identical to those caused by reticuloendotheliosis virus (strain T) infection. Examination of TV-1 cells by electron microscope revealed the presence of C-type virions budding from the plasma membrane. Cytotoxicity assays and fluorescent antibody tests indicated the presence of Bcell determinants on the TV-1 cell surface membrane.
The T-strain of a reticuloendotheliosis virus (REV-T) was first described by Sevoian et al. (12) as an avian leukosis virus with high lethality and a short incubation period when injected into various genetic lines of chickens. REV-T was then originally cultured from spontaneous lymphomas in adult turkeys (11) and was later studied in Japanese quail and chickens (17) . REV-T was then characterized as antigenically distinct from other known avian leukosis viruses (13) , although they share a C-type morphology. REV-T is now considered a prototype of the reticuloendotheliosis group of viruses (9) and is the only virus of this group proven capable of inducing a neoplastic disease (2) . Although REV-T-transformed cells were shown to be present in livers and spleens of REV-T-infected chickens (1), attempts to culture these cells in vitro were unsuccessful until Franklin et al. (2) maintained a culture of the bone marrow cells of an REVinfected chick.
We now report the in vitro establishment and characterization of a REV-T-transformed lymphoblastoid cell line from the spleen of a moribund SPAFA (SPAFAS, Inc., Norwich, Conn.) chick infected with REV-T.
MATERIALS AND METHODS
Cell line establishment. REV-T-infected cells were obtained from the dissociation of a splenic lymphoma in a Ten-Broek grinder. The splenic cells were washed twice with phosphate-buffered isotonic saline (PBS) (pH 7.2) before being layered on Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, N.J.) for separation of the buffy coat. The separated cells were then washed three times in PBS and suspended in culture medium RPMI 1640, supplemented as previously described (3) , to a cell density of 5 x 105 to 1 x 10' cells per ml. The cells were incubated in 50-ml volumes in glass bottles at 37 and 41'C in a 5% C02-in-air atmosphere. Cultures were transferred to fresh glass bottles after 2 days of incubation. Thereafter, the top 2/3 of the culture medium was aspirated and replaced with fresh medium every 2 to 3 days or when a pH change was evident.
Growth studies. REV-T-transformed cells were suspended in fresh RPMI 1640 medium at a density of 5 X 105 cells per ml. To determine cell replication and viability, assays were performed daily by treating 0.5 ml of cell suspension with trypan blue and counting the viable cell population on a hemacytometer.
Karyotyping. Air-dried chromosome preparations of REV-T-transformed cells were made by a modification of the technique of Goh (4) . Cells (3 X 106) were subjected to colchicine arrest (10-6 M/ml for 4 h), to a hypotonic solution (3:1, distilled water-RPMI 1640) treatment for 20 min, and then to three 10-min treatments in freshly prepared fixative (3:1, methanolacetic acid). The final cell suspensions in fixative were dropped onto glass slides previously cleaned with acetone and wetted with distilled water. When the slides were completely air-dried, C banding patterns were induced by the alkaline-SSC method of Stefos and Arrighi (14) .
Electron microscopy. Lymphoblastoid cell pellets obtained from 30-ml samples of REV-T culture (10, Biological assay of cells and cell-free supernatant from REV-T-transformed cell line. Titrations of REV-T-transformed cells and cell-free culture supernatant were assayed in day-old chicks. Ten-fold serial dilutions in PBS were prepared from REV-Ttransformed cells (105 cells per ml) or from the culture supernatant, which had been filtered through a 0.22 ,um BioRad filter (BioRad Laboratories, Richmond, Calif.). Five birds were inoculated intra-abdominally with 1 ml of each dilution and maintained for 4 weeks in Horsfall isolation units. Chicks inoculated with culture supernatant dilutions were challenged 4 weeks postinoculation with 0.5 ml of liver and spleen homogenates from a moribund chick infected with REV-T.
Five birds per trial were maintained in separate units as uninoculated controls. All dead birds were necropsied and examined for gross lesions. Birds that died within 5 days postinoculation or had no gross lesions of the liver or spleen upon necropsy were considered nonspecific for T-virus. The 50% lethal dose (LD50) and 50% protective dose were calculated by the method of Reed and Muench (10) .
Antisera production. B-cell and T-cell antisera were produced in New Zealand white rabbits by giving rabbits 3 to 10 inoculations of bursal or thymic cell suspensions (5 X 106 to 10 x 106 cells per ml) from 3-to 4-week-old chickens at 6-to 10-day intervals. Pooled anti-T or anti-B sera from weekly bleedings were inactivated at 56°C for 30 min and absorbed twice with chicken liver and up to six times with either thymic or bursal cell homogenates. In addition, portions of T-cell and B-cell antisera were reabsorbed with either thymic or bursal cell homogenates, respectively, to insure specificity in fluorescent antibody and cytotoxicity assays.
REV-T was isolated from the plasma of freshly drawn heart blood (in 0.02 M ethylenediaminetetraacetic acid) from moribund REV-T-infected chicks. The plasma was centrifuged twice at 2,000 x g for 15 min to insure complete separation from residual cells, then centrifuged at 80,000 x g for 1 h in a Beckman model L Ultracentrifuge (Beckman type SW50L rotor). The virus pellets were suspended in 1 ml of Freund complete adjuvant and inoculated into New Zealand white rabbits. The rabbits were boosted twice with REV-T that had been obtained as described above and suspended in 1 ml of PBS. Serum was pooled from weekly bleedings, inactivated at 56°C for 30 min, and extensively absorbed with chicken thymus, bursa, spleen, and liver tissue.
Antimacrophage serum was prepared and kindly provided by Keith Haffer of this department. Marek's disease-associated tumor-specific antigen antiserum was produced in chickens inoculated with JMV-1 (7), a nonproductive Marek's disease herpesvirus-transformed T-cell line, and Marek's disease virus (MDV) antiserum was obtained from chickens which were naturally infected with MDV by contact exposure. Both antisera were prepared and kindly provided by David C. Munch of this department.
Fluorescent antibody staining. REV-T-transformed cells were stained with T-cell, B-cell, REV-T, and macrophage antisera by a modification of the indirect technique of Moller (6) using fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobulin G (Miles Labs, Inc., Kankakee, Ill.). In addition, REV-T-transformed cells were stained directly with FITC-protein A (Pharmacia Fine Chemicals, Piscataway, N.J.), diluted 1:2, to specifically stain for immunoglobulin G. Thymic and bursal cells and JM-1 cells, from a productive Marek's disease herpesvirus-transformed T-cell line (JM strain) (7) were included in all trials to distinguish nonspecific from specific staining reactions.
REV-T-transformed cells were also examined by immunofluorescent staining for possible contamination with both MDV and avian leukosis virus.
A 15-ml sample of 5 x 105 viable REV-T-transformed cells per liter was treated for 24 h with 12.5 yg of iododeoxyuridine (Sigma Chemical Co., St. Louis, Mo.) to induce MDV antigens. Iododeoxyuridinetreated and nontreated cells were acetone fixed overnight at -20°C and then stained for the presence of MDV. Non-acetone-fixed cells were stained with Marek's disease-associated tumor-specific antigen antiserum. All staining was performed by the indirect technique of Moller (6) using FITC-conjugated rabbit anti-chicken immunoglobulin G (Nutritional Biochemicals Corp., Cleveland, Ohio). Controls included JMV-1, JM-1, and purified spleen cells from non-JMexposed chicks kept in Horsfall isolation units.
To Karyotype analysis of these cells indicated the presence of a female chromosome (ZW) (Fig. 1) . This REV-T-transformed lymphoblastoid cell line has been designated TV-1.
Microscopy. In suspension culture, TV-1 cells grew as single cells or in large aggregates which temporarily dissociated with gentle agitation. When stained with hematoxylin and eosin, the cells appeared pleomorphic and possessed a prominent nucleus. Mitotic figures were frequently observed (Fig. 2) .
When examined by an electron microscope, the lymphoblastoid cells appeared irregular in shape and frequently exhibited cytoplasmic processes. The cytoplasm was basophilic and contained numerous mitochondria, abundant polyribosomes, and a well-developed endoplasmic reticulum. A pronounced nucleolus and peripherally distributed chromatin were easily distinguishable within the large nucleus (Fig. 3) . 5), Ctype REV-T budding virions were observed in the region of the plasma membrane. However, no budding was evident within smooth-walled, intracytoplasmic vesicles. During release from the cell, the virus particles were seen in various stages of maturation. Intermediate and inner rings were observed in the nucleoid region of visions still associated with the plasma membrane, whereas an outer envelope and an intermediate layer surrounding a dense core were characteristic of REV-T particles located extracellularly (Fig. 4) .
Assay for infectivity. TV-1 cells and their culture supernatant produced lesions typical of REV-T infection (8) when inoculated into various lines of 1-day-to 1-week-old chickens. Table  2 indicates the results of titrating TV-1 cells and TV-1 cell-free culture supernatant in 1-day-old chicks. The LD50 remained constant at 104-337 from 9 weeks after culture initiation to 104228 after 24 weeks of cell line growth. After 31 weeks of growth, the LD50 had dropped to 103,124.
The amount of infectious virus released into the culture supernatant was low as evidenced by the LD50 of 100&1. All birds that survived the initial dose were challenged with REV-T-infected liver and spleen tissue homogenate to determine whether immunity to T-virus was present. A 50% protective dose was calculated to be 102345.
All dead birds were necropsied and typically had mottled livers. In addition, splenomegaly and hepatomegaly were frequently found. Control birds had no lesions of T-virus infection.
Fluorescent antibody staining. The findings of fluorescent antibody staining for cell membrane and intracellular antigens are summarized in Table 3 . Positive staining of TV-1 cells resulted with B-cell antiserum (Fig. 5) . The presence of immunoglobulin on TV-1 cell surfaces was subsequently confirmed by positive staining with FITC-protein A. When T-cell and B-cell antisera were absorbed with T-and Bcells, respectively, no significant membrane staining of any cell population was evident.
The absence of MDV and ALV contaminants was verified by the lack of fluorescent staining of TV-1 cells, including those that had been treated with iododeoxyuridine, when stained with anti-MDV, anti-Rous sarcoma virus, or anti-Marek's disease-associated tumor-specific antigen serum, in the presence of appropriate controls. Furthermore, CEF cultures that were infected with virus obtained from TV-1 cell culture supernatant produced no cytopathic effects characteristic of Marek's disease herpesvirus. Although in 25% of the CEF culture trials foci of dead cells, as described by Temin x 10' cells per ml, and it has been growing in suspension culture for at least 74 weeks.
We observed the cells to be pleomorphic and to grow primarily in large aggregates. Ultrastructurally, the presence of abundant ribosomes, free and attached, suggested active protein synthesis related to cell proliferation and to the synthesis of protein for export. The REV-T budding was found to be associated with cytoplasmic processes of the plasma membrane but was not observed within intracytoplasmic vesicles. The amount of virus released from the cell was found to be low. The LD5o values obtained for both cell-associated and cell-free virus were lower than values obtained by Sevoian et al. (12) in mortality studies of 1-day-old chicks tested with cellular and cell-free preparations of liver homogenate from moribund REV-T-infected chicks. However, the mortality patterns and histopathological lesions resulting from TV-1 cell and cell-free culture supernatant inoculation of 1-day-old chicks were indistinguishable from those obtained by inoculation of REV-T-infected tissue homogenate. In both instances, chicks showed no sign of illness until a few hours before death, and most deaths occurred 6 to 10 days postinoculation. Upon necropsy, greatly enlarged and mottled livers and spleens were consistently found. The demonstration of a female karyotype for TV-1 cells was remarkable in the light of the observations of Stephans et al. (15) and Hahn et al. (3) ; who found that the JMV lymphoblastic leukemic cell line was always of female karyotype. It has been speculated that the discrepancies in transplantability studies with JMV may be indicative of an initial proliferation of transplanted lymphocytes, followed by a late proliferation of host lymphocytes (D. C. Munch, Ph.D. dissertation, University of Massachusetts, Amherst, 1978). Insofar as both TV-1 cell-free supernatant and TV-1 cells produced typical reticuloendotheliosis in chicks, it appeared unlikely that TV-1 was acting as a cell transplant. However, the difference in chick lethality caused by REV-T-infected tissue homogenate versus TV-1 cells and their culture supernatant, combined with the female karyotype of the TV-1 cell line, suggested that the function of REV-T was altered in vitro and that transplantability studies with the TV-1 cell line would be informative.
Positive staining of TV-1 cells with B-cell antiserum and with FITC-protein A by fluorescent antibody technique showed the presence of cell surface immunoglobulin indicative of Bcells. Lysis of TV-1 cells by B-cell antiserum in the cytotoxicity assay also indicated the presence of B-cell determinants on membrane surfaces. The identification of TV-1 as a B-cell was further supported by ultrastructure studies which showed the presence of abundant endoplasmic reticulum within the cells.
It is anticipated that the establishment of the TV-1 cell line and its characterization as a female, B-cell line will facilitate further research related to the mechanisms of viral cell transformation and tumor cell immunity.
